AH Equity Partners LSV Ii, LLC

AH Equity Partners BIO II, LLC sells 5,000,000 shares at $2.35, reducing stake by 83.7%, leaving 971,885 shares

AH Equity Partners BIO II, LLC, a 10% owner, executed 2 separate sales totaling 5,000,000 shares for $11,750,000.00 on 2026-06-02 at a blended average price of $2.35. This reduction decreased the filer's holdings from 5,971,885 shares to 971,885 shares, representing a -83.7% net change in pre-transaction holdings. The sales occurred at $2.35 while the current price stands at $2.68, and notably, the company reported a full-year net income of $-14,697,000.00, indicating material operating losses. The magnitude of this exit—reducing a substantial ownership position to a minimal stake—combined with the company's unprofitable financial profile, suggests a significant repositioning by a major shareholder.

Andreessen Horowitz LSV Fund I (10% owner) bought 46,337 shares of NAVN at $18.11 on 2026-01-07; stock now at $17.28, -14.8% from 52-week high.

Andreessen Horowitz LSV Fund I purchased 46,337 shares at $18.11, adding to a substantial existing position of 8.35M shares. The timing is notable: this buy occurred just one day after another purchase at the same entity and represents the fifth consecutive buy within a 12-day window (2025-12-26 through 2026-01-07). The stock has declined -14.8% from its 52-week high of $20.28, yet the fund continued accumulating during this pullback. However, the target company faces significant headwinds—a net loss of $-225.4M against revenue of $194.9M—which raises questions about whether this sustained buying reflects conviction in a turnaround or simply structured rebalancing by a large stakeholder. A cluster pattern with 3 other insiders buying within 14 days adds some validation to the appetite, though none of the prior same-ticker transactions at NAVN have measurable 30- or 90-day outcomes yet.

Andreessen Horowitz LSV Fund I bought 976,975 shares of NAVN over 3 days for $15.9M at blended average of $16.31

Andreessen Horowitz LSV Fund I, a 10% owner, executed 3 separate purchases totaling 976,975 shares for $15,938,867.11 between January 2–6, 2026, increasing its holding by 13.3% to 8,300,455 shares. The filing occurs during a period of positive near-term momentum: the stock has gained +21.5% over the past 30 days and is currently trading at $17.00, above the blended purchase average of $16.31. However, critical context tempers the signal: NAVN posted a net loss of $-225,389,000.00 against revenue of $194,934,000.00 in its latest quarter, and the company's market cap stands at only $778,308,807.00. The timing also merits caution—the company is executing five consecutive buy transactions at this ticker within 7 calendar days (December 22–January 6), a pattern that has not yet demonstrated measurable 90-day outcomes at NAVN, and the insider's broader cross-ticker track record shows a 16.67% well-timed sell rate (12 prior sells with only 2 well-timed), suggesting limited historical precision in market timing.

Andreessen Horowitz LSV Fund I bought 1,056,534 shares ($16.7M) in 5 trades Dec 22–29 at blended $15.83; fund now holds 7,323,480 shares post-transaction.

Andreessen Horowitz LSV Fund I executed 5 separate purchases totaling 1,056,534 shares for $16,723,633.14 across a one-week window (2025-12-22 through 2025-12-29), increasing its stake by +16.9% from 6,266,946 to 7,323,480 shares. The blended average purchase price of $15.83 sits below the current price of $16.50, though the stock is -18.6% from its 52-week high of $20.28. The purchase cluster coincides with 4 other insiders buying within the same 14-day period, establishing a coordinated pattern of insider accumulation. This multi-tranche acquisition by a 10% owner during a period of financial loss (latest quarter net income of $-225,389,000.00 against revenue of $194,934,000.00) warrants attention to the fund's underlying rationale, though the limited same-ticker trading history and unproven track record at NAVN (three prior buy-dates all within days of this filing, with no measurable outcomes yet) offer minimal historical context to assess execution quality or predictive value at this specific security.

Andreessen Horowitz LSV Fund I acquired 692,395 shares over 3 days (Dec 17–19) for $9.4M at blended avg $13.51; NAVN cluster buy pattern with 4 other insiders

Andreessen Horowitz LSV Fund I executed 3 separate purchases totaling 692,395 shares for $9,352,310.10 between December 17–19, 2025, increasing its holdings from 5,574,551 to 6,266,946 shares (+12.4%). The transactions were priced at $12.65, $13.61, and $14.70 respectively, establishing a blended average of $13.51, while the stock currently trades at $15.11 and stands 25.5% below its 52-week high of $20.28. The company reported revenue of $194,934,000.00 but posted a net loss of $225,389,000.00 in its latest quarter, with a market cap of $691,779,180.81. Critically, this purchase occurred amid a cluster pattern in which 4 other insiders also bought within the past 14 days, suggesting coordinated confidence at these price levels. The 3-transaction structure and multi-day execution across a widening price range indicate deliberate accumulation rather than a single discretionary commitment.